昊海生物科技(06826.HK):散光人工晶狀體產品獲得歐盟CE認證
格隆匯 4 月 9日丨昊海生物科技(06826.HK)公吿,上海昊海生物科技股份有限公司(以下簡稱“公司”)控股子公司河南賽美視生物科技有限公司於近日獲得了關於可摺疊、疏水丙烯酸酯、非球面、散光人工晶狀體產品(以下簡稱“產品”或“產品”)的歐盟CE認證證書。產品生產工藝採用創新性模注成型工藝,系公司首個於全球範圍內獲得上市許可的具有矯正角膜散光功能的新型人工晶狀體。
產品採用創新性模注生產工藝,系可摺疊、疏水性丙烯酸酯、非球面、散光人工晶狀體,用於白內障手術後無晶狀體眼,替代原有人體晶狀體,並且能夠改善遠視力,矯正角膜散光。
白內障患者術前一般存在不同程度的角膜散光,普通人工晶狀體對於散光無明顯的矯正。相較於普通人工晶狀體產品,產品是針對白內障患者身存在角膜散光而設計的屈光性人工晶狀體,能夠有效矯正患者術後角膜散光,提高患者術後的視覺質量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.